Lopes-Virella MF - Search Results

1

Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.

Fu D, Yu JY, Wu M, Du M, Chen Y, Abdelsamie SA, Li Y, Chen J, Boulton ME, Ma JX, Lopes-Virella MF, Virella G, Lyons TJ. Fu D, et al. J Lipid Res. 2014 May;55(5):860-9. doi: 10.1194/jlr.M045401. Epub 2014 Mar 10. J Lipid Res. 2014. PMID: 24616481 Free PMC article.

2

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.

Zhang Y, Jenkins AJ, Basu A, Stoner JA, Lopes-Virella MF, Klein RL; DCCT/EDIC Research Group; Lyons TJ. Zhang Y, et al. J Lipid Res. 2016 Feb;57(2):310-7. doi: 10.1194/jlr.P060657. Epub 2015 Dec 9. J Lipid Res. 2016. PMID: 26658239 Free PMC article.

3

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF. Saad AF, et al. J Lipid Res. 2006 Sep;47(9):1975-83. doi: 10.1194/jlr.M600064-JLR200. Epub 2006 Jun 27. J Lipid Res. 2006. PMID: 16804192 Free article.

4

Clinical significance of the humoral immune response to modified LDL.

Lopes-Virella MF, Virella G. Lopes-Virella MF, et al. Clin Immunol. 2010 Jan;134(1):55-65. doi: 10.1016/j.clim.2009.04.001. Epub 2009 May 8. Clin Immunol. 2010. PMID: 19427818 Free PMC article. Review.

5

Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.

Abdelsamie SA, Li Y, Huang Y, Lee MH, Klein RL, Virella G, Lopes-Virella MF. Abdelsamie SA, et al. Clin Immunol. 2011 Jun;139(3):258-66. doi: 10.1016/j.clim.2011.01.016. Epub 2011 Feb 10. Clin Immunol. 2011. PMID: 21439910 Free PMC article.

6

Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis.

Lopes-Virella MF, Virella G. Lopes-Virella MF, et al. J Atheroscler Thromb. 2013;20(10):743-54. doi: 10.5551/jat.19281. Epub 2013 Aug 20. J Atheroscler Thromb. 2013. PMID: 23965492 Free article. Review.

7

Modified LDL Immune Complexes and Cardiovascular Disease.

Lopes-Virella MF, Virella G. Lopes-Virella MF, et al. Curr Med Chem. 2019;26(9):1680-1692. doi: 10.2174/0929867325666180524114429. Curr Med Chem. 2019. PMID: 29792135 Review.

8

LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-1.

Fu Y, Huang Y, Bandyopadhyay S, Virella G, Lopes-Virella MF. Fu Y, et al. J Lipid Res. 2003 Jul;44(7):1315-21. doi: 10.1194/jlr.M200415-JLR200. Epub 2003 May 1. J Lipid Res. 2003. PMID: 12730303 Free article.

9

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.

Virella G, Thorpe SR, Alderson NL, Derrick MB, Chassereau C, Rhett JM, Lopes-Virella MF. Virella G, et al. J Lipid Res. 2004 Oct;45(10):1859-67. doi: 10.1194/jlr.M400095-JLR200. Epub 2004 Jul 16. J Lipid Res. 2004. PMID: 15258197 Free article.

10

Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Jenkins AJ, Fu D, Azar M, Stoner JA, Kaufman DG, Zhang S, Klein RL, Lopes-Virella MF, Ma JX, Lyons TJ; VADT investigators. Jenkins AJ, et al. J Diabetes Complications. 2014 May-Jun;28(3):353-9. doi: 10.1016/j.jdiacomp.2014.01.008. Epub 2014 Jan 17. J Diabetes Complications. 2014. PMID: 24560422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters